nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PTGS1—ulcerative colitis	0.268	1	CbGaD
Bortezomib—PTGS1—Olsalazine—ulcerative colitis	0.0538	0.126	CbGbCtD
Bortezomib—PTGS1—Balsalazide—ulcerative colitis	0.048	0.112	CbGbCtD
Bortezomib—PTGS1—Mesalazine—ulcerative colitis	0.0383	0.0895	CbGbCtD
Bortezomib—CYP1A1—Nicotine—ulcerative colitis	0.0275	0.0643	CbGbCtD
Bortezomib—CYP1A1—Cholecalciferol—ulcerative colitis	0.0247	0.0577	CbGbCtD
Bortezomib—PTGS1—Sulfasalazine—ulcerative colitis	0.0214	0.05	CbGbCtD
Bortezomib—CYP2C8—Nicotine—ulcerative colitis	0.0159	0.0371	CbGbCtD
Bortezomib—CYP3A4—Budesonide—ulcerative colitis	0.0148	0.0346	CbGbCtD
Bortezomib—CYP2C8—Cholecalciferol—ulcerative colitis	0.0143	0.0333	CbGbCtD
Bortezomib—CYP2C19—Nicotine—ulcerative colitis	0.0133	0.0311	CbGbCtD
Bortezomib—CYP1A2—Nicotine—ulcerative colitis	0.0123	0.0287	CbGbCtD
Bortezomib—CYP2C19—Cholecalciferol—ulcerative colitis	0.012	0.0279	CbGbCtD
Bortezomib—CYP2C9—Nicotine—ulcerative colitis	0.0111	0.0259	CbGbCtD
Bortezomib—CYP1A1—Dexamethasone—ulcerative colitis	0.0107	0.025	CbGbCtD
Bortezomib—CYP2D6—Nicotine—ulcerative colitis	0.0101	0.0237	CbGbCtD
Bortezomib—CYP2C9—Cholecalciferol—ulcerative colitis	0.00994	0.0232	CbGbCtD
Bortezomib—CYP2C8—Hydrocortisone—ulcerative colitis	0.00992	0.0232	CbGbCtD
Bortezomib—CYP2D6—Cholecalciferol—ulcerative colitis	0.00909	0.0212	CbGbCtD
Bortezomib—CYP2C19—Prednisone—ulcerative colitis	0.00829	0.0194	CbGbCtD
Bortezomib—CYP3A4—Methylprednisolone—ulcerative colitis	0.00661	0.0154	CbGbCtD
Bortezomib—CYP3A4—Nicotine—ulcerative colitis	0.00645	0.0151	CbGbCtD
Bortezomib—CYP2C8—Dexamethasone—ulcerative colitis	0.00617	0.0144	CbGbCtD
Bortezomib—CYP3A4—Cholecalciferol—ulcerative colitis	0.00578	0.0135	CbGbCtD
Bortezomib—CYP2C19—Dexamethasone—ulcerative colitis	0.00518	0.0121	CbGbCtD
Bortezomib—CYP3A4—Triamcinolone—ulcerative colitis	0.00501	0.0117	CbGbCtD
Bortezomib—CYP2C9—Dexamethasone—ulcerative colitis	0.0043	0.01	CbGbCtD
Bortezomib—CYP3A4—Betamethasone—ulcerative colitis	0.0043	0.01	CbGbCtD
Bortezomib—CYP3A4—Prednisolone—ulcerative colitis	0.00424	0.00991	CbGbCtD
Bortezomib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00402	0.0094	CbGbCtD
Bortezomib—CYP3A4—Prednisone—ulcerative colitis	0.00401	0.00936	CbGbCtD
Bortezomib—CYP2D6—Dexamethasone—ulcerative colitis	0.00393	0.00919	CbGbCtD
Bortezomib—PSMA1—epithelium—ulcerative colitis	0.00286	0.0673	CbGeAlD
Bortezomib—CYP3A4—Dexamethasone—ulcerative colitis	0.0025	0.00584	CbGbCtD
Bortezomib—PSMD1—smooth muscle tissue—ulcerative colitis	0.00231	0.0544	CbGeAlD
Bortezomib—CTSG—lymphoid tissue—ulcerative colitis	0.00229	0.054	CbGeAlD
Bortezomib—PSMA1—lymphoid tissue—ulcerative colitis	0.0022	0.0518	CbGeAlD
Bortezomib—PSMA1—digestive system—ulcerative colitis	0.00218	0.0512	CbGeAlD
Bortezomib—PSMD2—smooth muscle tissue—ulcerative colitis	0.00205	0.0482	CbGeAlD
Bortezomib—PSMB5—smooth muscle tissue—ulcerative colitis	0.0018	0.0423	CbGeAlD
Bortezomib—PSMD2—lymphoid tissue—ulcerative colitis	0.00164	0.0385	CbGeAlD
Bortezomib—PSMA1—liver—ulcerative colitis	0.00162	0.0381	CbGeAlD
Bortezomib—PSMD2—digestive system—ulcerative colitis	0.00162	0.0381	CbGeAlD
Bortezomib—PSMB1—smooth muscle tissue—ulcerative colitis	0.00157	0.037	CbGeAlD
Bortezomib—PSMB2—smooth muscle tissue—ulcerative colitis	0.00153	0.0361	CbGeAlD
Bortezomib—PSMD1—liver—ulcerative colitis	0.00136	0.032	CbGeAlD
Bortezomib—PSMB1—lymphoid tissue—ulcerative colitis	0.00126	0.0296	CbGeAlD
Bortezomib—PSMB1—digestive system—ulcerative colitis	0.00124	0.0292	CbGeAlD
Bortezomib—PSMB2—lymphoid tissue—ulcerative colitis	0.00123	0.0289	CbGeAlD
Bortezomib—PSMB2—digestive system—ulcerative colitis	0.00121	0.0285	CbGeAlD
Bortezomib—PSMD2—liver—ulcerative colitis	0.00121	0.0284	CbGeAlD
Bortezomib—PSMB8—liver—ulcerative colitis	0.0012	0.0282	CbGeAlD
Bortezomib—PSMB5—liver—ulcerative colitis	0.00106	0.0249	CbGeAlD
Bortezomib—SLC31A1—digestive system—ulcerative colitis	0.00105	0.0247	CbGeAlD
Bortezomib—PSMB1—liver—ulcerative colitis	0.000925	0.0218	CbGeAlD
Bortezomib—PSMB2—liver—ulcerative colitis	0.000902	0.0212	CbGeAlD
Bortezomib—SLC31A1—liver—ulcerative colitis	0.000781	0.0184	CbGeAlD
Bortezomib—PSMB8—Balsalazide—Olsalazine—ulcerative colitis	0.000643	0.155	CbGdCrCtD
Bortezomib—Nateglinide—PPARG—ulcerative colitis	0.000599	0.473	CrCbGaD
Bortezomib—CYP1A1—epithelium—ulcerative colitis	0.000468	0.011	CbGeAlD
Bortezomib—CYP2C19—digestive system—ulcerative colitis	0.000442	0.0104	CbGeAlD
Bortezomib—Nateglinide—PTGS1—ulcerative colitis	0.000442	0.349	CrCbGaD
Bortezomib—PTGS1—epithelium—ulcerative colitis	0.000411	0.00968	CbGeAlD
Bortezomib—PTGS1—smooth muscle tissue—ulcerative colitis	0.000396	0.00933	CbGeAlD
Bortezomib—PSMB8—Balsalazide—Sulfasalazine—ulcerative colitis	0.000369	0.0891	CbGdCrCtD
Bortezomib—CYP1A2—digestive system—ulcerative colitis	0.000361	0.0085	CbGeAlD
Bortezomib—CYP1A1—digestive system—ulcerative colitis	0.000356	0.00838	CbGeAlD
Bortezomib—CYP2C9—digestive system—ulcerative colitis	0.000343	0.00807	CbGeAlD
Bortezomib—CYP2C19—liver—ulcerative colitis	0.000329	0.00775	CbGeAlD
Bortezomib—PTGS1—digestive system—ulcerative colitis	0.000313	0.00737	CbGeAlD
Bortezomib—CYP2C8—liver—ulcerative colitis	0.000288	0.00677	CbGeAlD
Bortezomib—CYP1A2—liver—ulcerative colitis	0.000269	0.00633	CbGeAlD
Bortezomib—CYP1A1—liver—ulcerative colitis	0.000265	0.00625	CbGeAlD
Bortezomib—CYP3A4—digestive system—ulcerative colitis	0.000261	0.00615	CbGeAlD
Bortezomib—CYP2D6—digestive system—ulcerative colitis	0.000257	0.00605	CbGeAlD
Bortezomib—CYP2C9—liver—ulcerative colitis	0.000255	0.00601	CbGeAlD
Bortezomib—Nateglinide—ALB—ulcerative colitis	0.000225	0.178	CrCbGaD
Bortezomib—CYP3A4—liver—ulcerative colitis	0.000195	0.00458	CbGeAlD
Bortezomib—CYP2D6—liver—ulcerative colitis	0.000192	0.00451	CbGeAlD
Bortezomib—PSMB8—Fluorometholone—Budesonide—ulcerative colitis	0.000148	0.0357	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Budesonide—ulcerative colitis	0.000113	0.0272	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Hydrocortisone—ulcerative colitis	0.000105	0.0253	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Budesonide—ulcerative colitis	0.000104	0.0252	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Budesonide—ulcerative colitis	0.000104	0.0252	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	9.93e-05	0.024	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Methylprednisolone—ulcerative colitis	9.88e-05	0.0238	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Betamethasone—ulcerative colitis	9.78e-05	0.0236	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	9.78e-05	0.0236	CbGdCrCtD
Bortezomib—PSMD2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	9.55e-05	0.0231	CbGdCrCtD
Bortezomib—PSMB8—Medrysone—Prednisolone—ulcerative colitis	8.8e-05	0.0212	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Hydrocortisone—ulcerative colitis	7.58e-05	0.0183	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Methylprednisolone—ulcerative colitis	7.15e-05	0.0173	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Betamethasone—ulcerative colitis	7.04e-05	0.017	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Dexamethasone—ulcerative colitis	7.04e-05	0.017	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Triamcinolone—ulcerative colitis	6.88e-05	0.0166	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Prednisone—ulcerative colitis	6.53e-05	0.0158	CbGdCrCtD
Bortezomib—PSMB8—Fluorometholone—Prednisolone—ulcerative colitis	6.37e-05	0.0154	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Budesonide—ulcerative colitis	6.05e-05	0.0146	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Budesonide—ulcerative colitis	6.05e-05	0.0146	CbGdCrCtD
Bortezomib—PSMB8—Testosterone Propionate—Hydrocortisone—ulcerative colitis	5.83e-05	0.0141	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Methylprednisolone—ulcerative colitis	5.45e-05	0.0131	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Betamethasone—ulcerative colitis	5.36e-05	0.0129	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Dexamethasone—ulcerative colitis	5.36e-05	0.0129	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Hydrocortisone—ulcerative colitis	5.34e-05	0.0129	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Hydrocortisone—ulcerative colitis	5.34e-05	0.0129	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Triamcinolone—ulcerative colitis	5.24e-05	0.0126	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Methylprednisolone—ulcerative colitis	5.04e-05	0.0122	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Methylprednisolone—ulcerative colitis	5.04e-05	0.0122	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Prednisone—ulcerative colitis	4.97e-05	0.012	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Dexamethasone—ulcerative colitis	4.96e-05	0.012	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Betamethasone—ulcerative colitis	4.96e-05	0.012	CbGdCrCtD
Bortezomib—PSMB8—Diflorasone—Prednisolone—ulcerative colitis	4.85e-05	0.0117	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Triamcinolone—ulcerative colitis	4.84e-05	0.0117	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Triamcinolone—ulcerative colitis	4.84e-05	0.0117	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Prednisone—ulcerative colitis	4.6e-05	0.0111	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Prednisone—ulcerative colitis	4.6e-05	0.0111	CbGdCrCtD
Bortezomib—PSMD2—Betamethasone—Prednisolone—ulcerative colitis	4.49e-05	0.0108	CbGdCrCtD
Bortezomib—PSMD2—Dexamethasone—Prednisolone—ulcerative colitis	4.49e-05	0.0108	CbGdCrCtD
Bortezomib—PSMB8—Norethindrone—Hydrocortisone—ulcerative colitis	4.37e-05	0.0105	CbGdCrCtD
Bortezomib—Arthralgia—Methylprednisolone—ulcerative colitis	4.16e-05	0.000254	CcSEcCtD
Bortezomib—Myalgia—Methylprednisolone—ulcerative colitis	4.16e-05	0.000254	CcSEcCtD
Bortezomib—Eye disorder—Prednisone—ulcerative colitis	4.15e-05	0.000254	CcSEcCtD
Bortezomib—Anxiety—Methylprednisolone—ulcerative colitis	4.15e-05	0.000253	CcSEcCtD
Bortezomib—Tachycardia—Hydrocortisone—ulcerative colitis	4.14e-05	0.000253	CcSEcCtD
Bortezomib—Rash—Azathioprine—ulcerative colitis	4.13e-05	0.000252	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	4.13e-05	0.000252	CcSEcCtD
Bortezomib—Dermatitis—Azathioprine—ulcerative colitis	4.13e-05	0.000252	CcSEcCtD
Bortezomib—Flushing—Prednisone—ulcerative colitis	4.13e-05	0.000252	CcSEcCtD
Bortezomib—Skin disorder—Hydrocortisone—ulcerative colitis	4.12e-05	0.000252	CcSEcCtD
Bortezomib—Ill-defined disorder—Dexamethasone—ulcerative colitis	4.12e-05	0.000252	CcSEcCtD
Bortezomib—Ill-defined disorder—Betamethasone—ulcerative colitis	4.12e-05	0.000252	CcSEcCtD
Bortezomib—Discomfort—Triamcinolone—ulcerative colitis	4.12e-05	0.000252	CcSEcCtD
Bortezomib—Discomfort—Methylprednisolone—ulcerative colitis	4.11e-05	0.000251	CcSEcCtD
Bortezomib—Headache—Azathioprine—ulcerative colitis	4.11e-05	0.000251	CcSEcCtD
Bortezomib—Hyperhidrosis—Hydrocortisone—ulcerative colitis	4.1e-05	0.000251	CcSEcCtD
Bortezomib—Diarrhoea—Mesalazine—ulcerative colitis	4.08e-05	0.00025	CcSEcCtD
Bortezomib—Angioedema—Betamethasone—ulcerative colitis	4.06e-05	0.000248	CcSEcCtD
Bortezomib—Angioedema—Dexamethasone—ulcerative colitis	4.06e-05	0.000248	CcSEcCtD
Bortezomib—Anorexia—Hydrocortisone—ulcerative colitis	4.05e-05	0.000247	CcSEcCtD
Bortezomib—Angiopathy—Prednisone—ulcerative colitis	4.03e-05	0.000246	CcSEcCtD
Bortezomib—Confusional state—Methylprednisolone—ulcerative colitis	4.02e-05	0.000246	CcSEcCtD
Bortezomib—Immune system disorder—Prednisone—ulcerative colitis	4.02e-05	0.000245	CcSEcCtD
Bortezomib—Malaise—Betamethasone—ulcerative colitis	4.01e-05	0.000245	CcSEcCtD
Bortezomib—Malaise—Dexamethasone—ulcerative colitis	4.01e-05	0.000245	CcSEcCtD
Bortezomib—Anaphylactic shock—Triamcinolone—ulcerative colitis	4e-05	0.000244	CcSEcCtD
Bortezomib—Oedema—Triamcinolone—ulcerative colitis	4e-05	0.000244	CcSEcCtD
Bortezomib—Vertigo—Betamethasone—ulcerative colitis	3.99e-05	0.000244	CcSEcCtD
Bortezomib—Vertigo—Dexamethasone—ulcerative colitis	3.99e-05	0.000244	CcSEcCtD
Bortezomib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	3.99e-05	0.000244	CcSEcCtD
Bortezomib—Syncope—Betamethasone—ulcerative colitis	3.99e-05	0.000243	CcSEcCtD
Bortezomib—Syncope—Dexamethasone—ulcerative colitis	3.99e-05	0.000243	CcSEcCtD
Bortezomib—Arrhythmia—Prednisone—ulcerative colitis	3.97e-05	0.000243	CcSEcCtD
Bortezomib—Infection—Triamcinolone—ulcerative colitis	3.97e-05	0.000243	CcSEcCtD
Bortezomib—Hypotension—Hydrocortisone—ulcerative colitis	3.97e-05	0.000242	CcSEcCtD
Bortezomib—Infection—Methylprednisolone—ulcerative colitis	3.96e-05	0.000242	CcSEcCtD
Bortezomib—Dizziness—Mesalazine—ulcerative colitis	3.95e-05	0.000241	CcSEcCtD
Bortezomib—Shock—Triamcinolone—ulcerative colitis	3.93e-05	0.00024	CcSEcCtD
Bortezomib—Insomnia—Prednisolone—ulcerative colitis	3.93e-05	0.00024	CcSEcCtD
Bortezomib—Shock—Methylprednisolone—ulcerative colitis	3.92e-05	0.00024	CcSEcCtD
Bortezomib—Nervous system disorder—Methylprednisolone—ulcerative colitis	3.91e-05	0.000239	CcSEcCtD
Bortezomib—Loss of consciousness—Dexamethasone—ulcerative colitis	3.91e-05	0.000239	CcSEcCtD
Bortezomib—Loss of consciousness—Betamethasone—ulcerative colitis	3.91e-05	0.000239	CcSEcCtD
Bortezomib—Paraesthesia—Prednisolone—ulcerative colitis	3.9e-05	0.000238	CcSEcCtD
Bortezomib—Tachycardia—Triamcinolone—ulcerative colitis	3.9e-05	0.000238	CcSEcCtD
Bortezomib—Mental disorder—Prednisone—ulcerative colitis	3.89e-05	0.000238	CcSEcCtD
Bortezomib—Nausea—Azathioprine—ulcerative colitis	3.89e-05	0.000238	CcSEcCtD
Bortezomib—Tachycardia—Methylprednisolone—ulcerative colitis	3.89e-05	0.000238	CcSEcCtD
Bortezomib—Skin disorder—Methylprednisolone—ulcerative colitis	3.87e-05	0.000237	CcSEcCtD
Bortezomib—Erythema—Prednisone—ulcerative colitis	3.87e-05	0.000236	CcSEcCtD
Bortezomib—Malnutrition—Prednisone—ulcerative colitis	3.87e-05	0.000236	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	3.87e-05	0.000236	CcSEcCtD
Bortezomib—Hyperhidrosis—Triamcinolone—ulcerative colitis	3.86e-05	0.000236	CcSEcCtD
Bortezomib—Hyperhidrosis—Methylprednisolone—ulcerative colitis	3.86e-05	0.000236	CcSEcCtD
Bortezomib—Convulsion—Betamethasone—ulcerative colitis	3.85e-05	0.000235	CcSEcCtD
Bortezomib—Convulsion—Dexamethasone—ulcerative colitis	3.85e-05	0.000235	CcSEcCtD
Bortezomib—Insomnia—Hydrocortisone—ulcerative colitis	3.84e-05	0.000235	CcSEcCtD
Bortezomib—Hypertension—Betamethasone—ulcerative colitis	3.84e-05	0.000234	CcSEcCtD
Bortezomib—Hypertension—Dexamethasone—ulcerative colitis	3.84e-05	0.000234	CcSEcCtD
Bortezomib—Paraesthesia—Hydrocortisone—ulcerative colitis	3.81e-05	0.000233	CcSEcCtD
Bortezomib—Vomiting—Mesalazine—ulcerative colitis	3.8e-05	0.000232	CcSEcCtD
Bortezomib—Myalgia—Dexamethasone—ulcerative colitis	3.78e-05	0.000231	CcSEcCtD
Bortezomib—Myalgia—Betamethasone—ulcerative colitis	3.78e-05	0.000231	CcSEcCtD
Bortezomib—Anxiety—Dexamethasone—ulcerative colitis	3.77e-05	0.00023	CcSEcCtD
Bortezomib—Anxiety—Betamethasone—ulcerative colitis	3.77e-05	0.00023	CcSEcCtD
Bortezomib—Rash—Mesalazine—ulcerative colitis	3.76e-05	0.00023	CcSEcCtD
Bortezomib—Dermatitis—Mesalazine—ulcerative colitis	3.76e-05	0.00023	CcSEcCtD
Bortezomib—Headache—Mesalazine—ulcerative colitis	3.74e-05	0.000228	CcSEcCtD
Bortezomib—Discomfort—Betamethasone—ulcerative colitis	3.74e-05	0.000228	CcSEcCtD
Bortezomib—Discomfort—Dexamethasone—ulcerative colitis	3.74e-05	0.000228	CcSEcCtD
Bortezomib—Dyspepsia—Hydrocortisone—ulcerative colitis	3.74e-05	0.000228	CcSEcCtD
Bortezomib—Hypotension—Methylprednisolone—ulcerative colitis	3.73e-05	0.000228	CcSEcCtD
Bortezomib—Pain—Prednisolone—ulcerative colitis	3.72e-05	0.000227	CcSEcCtD
Bortezomib—Decreased appetite—Hydrocortisone—ulcerative colitis	3.69e-05	0.000225	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	3.66e-05	0.000224	CcSEcCtD
Bortezomib—Fatigue—Hydrocortisone—ulcerative colitis	3.66e-05	0.000224	CcSEcCtD
Bortezomib—Vision blurred—Prednisone—ulcerative colitis	3.65e-05	0.000223	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	3.64e-05	0.000222	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	3.63e-05	0.000222	CcSEcCtD
Bortezomib—Pain—Hydrocortisone—ulcerative colitis	3.63e-05	0.000222	CcSEcCtD
Bortezomib—Anaphylactic shock—Dexamethasone—ulcerative colitis	3.63e-05	0.000222	CcSEcCtD
Bortezomib—Anaphylactic shock—Betamethasone—ulcerative colitis	3.63e-05	0.000222	CcSEcCtD
Bortezomib—Oedema—Dexamethasone—ulcerative colitis	3.63e-05	0.000222	CcSEcCtD
Bortezomib—Oedema—Betamethasone—ulcerative colitis	3.63e-05	0.000222	CcSEcCtD
Bortezomib—Insomnia—Triamcinolone—ulcerative colitis	3.62e-05	0.000221	CcSEcCtD
Bortezomib—Insomnia—Methylprednisolone—ulcerative colitis	3.61e-05	0.00022	CcSEcCtD
Bortezomib—Infection—Betamethasone—ulcerative colitis	3.6e-05	0.00022	CcSEcCtD
Bortezomib—Infection—Dexamethasone—ulcerative colitis	3.6e-05	0.00022	CcSEcCtD
Bortezomib—Ill-defined disorder—Prednisone—ulcerative colitis	3.59e-05	0.000219	CcSEcCtD
Bortezomib—Paraesthesia—Triamcinolone—ulcerative colitis	3.59e-05	0.000219	CcSEcCtD
Bortezomib—Feeling abnormal—Prednisolone—ulcerative colitis	3.58e-05	0.000219	CcSEcCtD
Bortezomib—Paraesthesia—Methylprednisolone—ulcerative colitis	3.58e-05	0.000219	CcSEcCtD
Bortezomib—Anaemia—Prednisone—ulcerative colitis	3.58e-05	0.000219	CcSEcCtD
Bortezomib—Shock—Betamethasone—ulcerative colitis	3.57e-05	0.000218	CcSEcCtD
Bortezomib—Shock—Dexamethasone—ulcerative colitis	3.57e-05	0.000218	CcSEcCtD
Bortezomib—Dyspnoea—Triamcinolone—ulcerative colitis	3.56e-05	0.000218	CcSEcCtD
Bortezomib—Nervous system disorder—Betamethasone—ulcerative colitis	3.56e-05	0.000217	CcSEcCtD
Bortezomib—Nervous system disorder—Dexamethasone—ulcerative colitis	3.56e-05	0.000217	CcSEcCtD
Bortezomib—Agitation—Prednisone—ulcerative colitis	3.56e-05	0.000217	CcSEcCtD
Bortezomib—Thrombocytopenia—Betamethasone—ulcerative colitis	3.55e-05	0.000217	CcSEcCtD
Bortezomib—Thrombocytopenia—Dexamethasone—ulcerative colitis	3.55e-05	0.000217	CcSEcCtD
Bortezomib—Nausea—Mesalazine—ulcerative colitis	3.55e-05	0.000217	CcSEcCtD
Bortezomib—Tachycardia—Betamethasone—ulcerative colitis	3.54e-05	0.000216	CcSEcCtD
Bortezomib—Tachycardia—Dexamethasone—ulcerative colitis	3.54e-05	0.000216	CcSEcCtD
Bortezomib—Angioedema—Prednisone—ulcerative colitis	3.54e-05	0.000216	CcSEcCtD
Bortezomib—Dyspepsia—Triamcinolone—ulcerative colitis	3.52e-05	0.000215	CcSEcCtD
Bortezomib—Dyspepsia—Methylprednisolone—ulcerative colitis	3.51e-05	0.000214	CcSEcCtD
Bortezomib—Hyperhidrosis—Betamethasone—ulcerative colitis	3.51e-05	0.000214	CcSEcCtD
Bortezomib—Hyperhidrosis—Dexamethasone—ulcerative colitis	3.51e-05	0.000214	CcSEcCtD
Bortezomib—Feeling abnormal—Hydrocortisone—ulcerative colitis	3.5e-05	0.000214	CcSEcCtD
Bortezomib—Malaise—Prednisone—ulcerative colitis	3.49e-05	0.000213	CcSEcCtD
Bortezomib—PSMB8—Levonorgestrel—Hydrocortisone—ulcerative colitis	3.48e-05	0.00839	CbGdCrCtD
Bortezomib—Vertigo—Prednisone—ulcerative colitis	3.48e-05	0.000212	CcSEcCtD
Bortezomib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	3.47e-05	0.000212	CcSEcCtD
Bortezomib—Syncope—Prednisone—ulcerative colitis	3.47e-05	0.000212	CcSEcCtD
Bortezomib—Anorexia—Dexamethasone—ulcerative colitis	3.46e-05	0.000211	CcSEcCtD
Bortezomib—Anorexia—Betamethasone—ulcerative colitis	3.46e-05	0.000211	CcSEcCtD
Bortezomib—Urticaria—Prednisolone—ulcerative colitis	3.45e-05	0.000211	CcSEcCtD
Bortezomib—Fatigue—Triamcinolone—ulcerative colitis	3.45e-05	0.000211	CcSEcCtD
Bortezomib—Fatigue—Methylprednisolone—ulcerative colitis	3.44e-05	0.00021	CcSEcCtD
Bortezomib—Pain—Triamcinolone—ulcerative colitis	3.42e-05	0.000209	CcSEcCtD
Bortezomib—Loss of consciousness—Prednisone—ulcerative colitis	3.4e-05	0.000208	CcSEcCtD
Bortezomib—Hypotension—Dexamethasone—ulcerative colitis	3.39e-05	0.000207	CcSEcCtD
Bortezomib—Hypotension—Betamethasone—ulcerative colitis	3.39e-05	0.000207	CcSEcCtD
Bortezomib—Urticaria—Hydrocortisone—ulcerative colitis	3.37e-05	0.000206	CcSEcCtD
Bortezomib—Body temperature increased—Hydrocortisone—ulcerative colitis	3.36e-05	0.000205	CcSEcCtD
Bortezomib—Abdominal pain—Hydrocortisone—ulcerative colitis	3.36e-05	0.000205	CcSEcCtD
Bortezomib—Convulsion—Prednisone—ulcerative colitis	3.35e-05	0.000205	CcSEcCtD
Bortezomib—Hypertension—Prednisone—ulcerative colitis	3.34e-05	0.000204	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	3.3e-05	0.000202	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	3.3e-05	0.000202	CcSEcCtD
Bortezomib—Myalgia—Prednisone—ulcerative colitis	3.29e-05	0.000201	CcSEcCtD
Bortezomib—Arthralgia—Prednisone—ulcerative colitis	3.29e-05	0.000201	CcSEcCtD
Bortezomib—Feeling abnormal—Triamcinolone—ulcerative colitis	3.29e-05	0.000201	CcSEcCtD
Bortezomib—Feeling abnormal—Methylprednisolone—ulcerative colitis	3.29e-05	0.000201	CcSEcCtD
Bortezomib—Anxiety—Prednisone—ulcerative colitis	3.28e-05	0.000201	CcSEcCtD
Bortezomib—Insomnia—Dexamethasone—ulcerative colitis	3.28e-05	0.0002	CcSEcCtD
Bortezomib—Insomnia—Betamethasone—ulcerative colitis	3.28e-05	0.0002	CcSEcCtD
Bortezomib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	3.27e-05	0.0002	CcSEcCtD
Bortezomib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	3.26e-05	0.000199	CcSEcCtD
Bortezomib—Paraesthesia—Betamethasone—ulcerative colitis	3.26e-05	0.000199	CcSEcCtD
Bortezomib—Paraesthesia—Dexamethasone—ulcerative colitis	3.26e-05	0.000199	CcSEcCtD
Bortezomib—Discomfort—Prednisone—ulcerative colitis	3.26e-05	0.000199	CcSEcCtD
Bortezomib—Hypersensitivity—Prednisolone—ulcerative colitis	3.2e-05	0.000196	CcSEcCtD
Bortezomib—Dyspepsia—Dexamethasone—ulcerative colitis	3.19e-05	0.000195	CcSEcCtD
Bortezomib—Dyspepsia—Betamethasone—ulcerative colitis	3.19e-05	0.000195	CcSEcCtD
Bortezomib—Urticaria—Triamcinolone—ulcerative colitis	3.18e-05	0.000194	CcSEcCtD
Bortezomib—Urticaria—Methylprednisolone—ulcerative colitis	3.17e-05	0.000194	CcSEcCtD
Bortezomib—Body temperature increased—Triamcinolone—ulcerative colitis	3.16e-05	0.000193	CcSEcCtD
Bortezomib—Anaphylactic shock—Prednisone—ulcerative colitis	3.16e-05	0.000193	CcSEcCtD
Bortezomib—Oedema—Prednisone—ulcerative colitis	3.16e-05	0.000193	CcSEcCtD
Bortezomib—Abdominal pain—Methylprednisolone—ulcerative colitis	3.15e-05	0.000193	CcSEcCtD
Bortezomib—Decreased appetite—Betamethasone—ulcerative colitis	3.15e-05	0.000193	CcSEcCtD
Bortezomib—Decreased appetite—Dexamethasone—ulcerative colitis	3.15e-05	0.000193	CcSEcCtD
Bortezomib—Infection—Prednisone—ulcerative colitis	3.14e-05	0.000192	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	3.13e-05	0.000191	CcSEcCtD
Bortezomib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	3.13e-05	0.000191	CcSEcCtD
Bortezomib—Hypersensitivity—Hydrocortisone—ulcerative colitis	3.13e-05	0.000191	CcSEcCtD
Bortezomib—Fatigue—Betamethasone—ulcerative colitis	3.13e-05	0.000191	CcSEcCtD
Bortezomib—Fatigue—Dexamethasone—ulcerative colitis	3.13e-05	0.000191	CcSEcCtD
Bortezomib—Shock—Prednisone—ulcerative colitis	3.11e-05	0.00019	CcSEcCtD
Bortezomib—Pain—Betamethasone—ulcerative colitis	3.1e-05	0.000189	CcSEcCtD
Bortezomib—Pain—Dexamethasone—ulcerative colitis	3.1e-05	0.000189	CcSEcCtD
Bortezomib—Nervous system disorder—Prednisone—ulcerative colitis	3.1e-05	0.000189	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Hydrocortisone—ulcerative colitis	3.1e-05	0.00747	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Hydrocortisone—ulcerative colitis	3.1e-05	0.00747	CbGdCrCtD
Bortezomib—Tachycardia—Prednisone—ulcerative colitis	3.08e-05	0.000188	CcSEcCtD
Bortezomib—Skin disorder—Prednisone—ulcerative colitis	3.07e-05	0.000187	CcSEcCtD
Bortezomib—Hyperhidrosis—Prednisone—ulcerative colitis	3.05e-05	0.000187	CcSEcCtD
Bortezomib—Asthenia—Hydrocortisone—ulcerative colitis	3.05e-05	0.000186	CcSEcCtD
Bortezomib—Anorexia—Prednisone—ulcerative colitis	3.01e-05	0.000184	CcSEcCtD
Bortezomib—Pruritus—Hydrocortisone—ulcerative colitis	3e-05	0.000183	CcSEcCtD
Bortezomib—Feeling abnormal—Betamethasone—ulcerative colitis	2.99e-05	0.000183	CcSEcCtD
Bortezomib—Feeling abnormal—Dexamethasone—ulcerative colitis	2.99e-05	0.000183	CcSEcCtD
Bortezomib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	2.97e-05	0.000181	CcSEcCtD
Bortezomib—Gastrointestinal pain—Betamethasone—ulcerative colitis	2.97e-05	0.000181	CcSEcCtD
Bortezomib—Hypersensitivity—Triamcinolone—ulcerative colitis	2.94e-05	0.00018	CcSEcCtD
Bortezomib—Hypersensitivity—Methylprednisolone—ulcerative colitis	2.94e-05	0.00018	CcSEcCtD
Bortezomib—PSMB8—Dexamethasone—Methylprednisolone—ulcerative colitis	2.92e-05	0.00705	CbGdCrCtD
Bortezomib—PSMB8—Betamethasone—Methylprednisolone—ulcerative colitis	2.92e-05	0.00705	CbGdCrCtD
Bortezomib—Diarrhoea—Hydrocortisone—ulcerative colitis	2.9e-05	0.000177	CcSEcCtD
Bortezomib—Urticaria—Dexamethasone—ulcerative colitis	2.88e-05	0.000176	CcSEcCtD
Bortezomib—Urticaria—Betamethasone—ulcerative colitis	2.88e-05	0.000176	CcSEcCtD
Bortezomib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	2.88e-05	0.000176	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Dexamethasone—ulcerative colitis	2.88e-05	0.00694	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Betamethasone—ulcerative colitis	2.88e-05	0.00694	CbGdCrCtD
Bortezomib—Dizziness—Prednisolone—ulcerative colitis	2.87e-05	0.000176	CcSEcCtD
Bortezomib—Asthenia—Triamcinolone—ulcerative colitis	2.87e-05	0.000175	CcSEcCtD
Bortezomib—Body temperature increased—Dexamethasone—ulcerative colitis	2.87e-05	0.000175	CcSEcCtD
Bortezomib—Abdominal pain—Dexamethasone—ulcerative colitis	2.87e-05	0.000175	CcSEcCtD
Bortezomib—Body temperature increased—Betamethasone—ulcerative colitis	2.87e-05	0.000175	CcSEcCtD
Bortezomib—Abdominal pain—Betamethasone—ulcerative colitis	2.87e-05	0.000175	CcSEcCtD
Bortezomib—Asthenia—Methylprednisolone—ulcerative colitis	2.86e-05	0.000175	CcSEcCtD
Bortezomib—Insomnia—Prednisone—ulcerative colitis	2.86e-05	0.000175	CcSEcCtD
Bortezomib—Paraesthesia—Prednisone—ulcerative colitis	2.84e-05	0.000173	CcSEcCtD
Bortezomib—Pruritus—Triamcinolone—ulcerative colitis	2.83e-05	0.000173	CcSEcCtD
Bortezomib—Pruritus—Methylprednisolone—ulcerative colitis	2.82e-05	0.000172	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Triamcinolone—ulcerative colitis	2.81e-05	0.00678	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Triamcinolone—ulcerative colitis	2.81e-05	0.00678	CbGdCrCtD
Bortezomib—Dizziness—Hydrocortisone—ulcerative colitis	2.81e-05	0.000171	CcSEcCtD
Bortezomib—Dyspepsia—Prednisone—ulcerative colitis	2.78e-05	0.00017	CcSEcCtD
Bortezomib—Decreased appetite—Prednisone—ulcerative colitis	2.75e-05	0.000168	CcSEcCtD
Bortezomib—Rash—Prednisolone—ulcerative colitis	2.74e-05	0.000167	CcSEcCtD
Bortezomib—Dermatitis—Prednisolone—ulcerative colitis	2.74e-05	0.000167	CcSEcCtD
Bortezomib—Diarrhoea—Methylprednisolone—ulcerative colitis	2.73e-05	0.000167	CcSEcCtD
Bortezomib—Fatigue—Prednisone—ulcerative colitis	2.72e-05	0.000166	CcSEcCtD
Bortezomib—Headache—Prednisolone—ulcerative colitis	2.72e-05	0.000166	CcSEcCtD
Bortezomib—Constipation—Prednisone—ulcerative colitis	2.7e-05	0.000165	CcSEcCtD
Bortezomib—Vomiting—Hydrocortisone—ulcerative colitis	2.7e-05	0.000165	CcSEcCtD
Bortezomib—Rash—Hydrocortisone—ulcerative colitis	2.68e-05	0.000164	CcSEcCtD
Bortezomib—Dermatitis—Hydrocortisone—ulcerative colitis	2.67e-05	0.000163	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Prednisone—ulcerative colitis	2.67e-05	0.00643	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Prednisone—ulcerative colitis	2.67e-05	0.00643	CbGdCrCtD
Bortezomib—Headache—Hydrocortisone—ulcerative colitis	2.66e-05	0.000162	CcSEcCtD
Bortezomib—Dizziness—Triamcinolone—ulcerative colitis	2.64e-05	0.000161	CcSEcCtD
Bortezomib—Dizziness—Methylprednisolone—ulcerative colitis	2.64e-05	0.000161	CcSEcCtD
Bortezomib—Feeling abnormal—Prednisone—ulcerative colitis	2.6e-05	0.000159	CcSEcCtD
Bortezomib—PSMB8—Betamethasone—Prednisolone—ulcerative colitis	2.6e-05	0.00628	CbGdCrCtD
Bortezomib—PSMB8—Dexamethasone—Prednisolone—ulcerative colitis	2.6e-05	0.00628	CbGdCrCtD
Bortezomib—Asthenia—Dexamethasone—ulcerative colitis	2.6e-05	0.000159	CcSEcCtD
Bortezomib—Asthenia—Betamethasone—ulcerative colitis	2.6e-05	0.000159	CcSEcCtD
Bortezomib—Gastrointestinal pain—Prednisone—ulcerative colitis	2.58e-05	0.000158	CcSEcCtD
Bortezomib—Nausea—Prednisolone—ulcerative colitis	2.58e-05	0.000158	CcSEcCtD
Bortezomib—Pruritus—Dexamethasone—ulcerative colitis	2.57e-05	0.000157	CcSEcCtD
Bortezomib—Pruritus—Betamethasone—ulcerative colitis	2.57e-05	0.000157	CcSEcCtD
Bortezomib—Vomiting—Triamcinolone—ulcerative colitis	2.54e-05	0.000155	CcSEcCtD
Bortezomib—Vomiting—Methylprednisolone—ulcerative colitis	2.54e-05	0.000155	CcSEcCtD
Bortezomib—Nausea—Hydrocortisone—ulcerative colitis	2.52e-05	0.000154	CcSEcCtD
Bortezomib—Rash—Triamcinolone—ulcerative colitis	2.52e-05	0.000154	CcSEcCtD
Bortezomib—Dermatitis—Triamcinolone—ulcerative colitis	2.52e-05	0.000154	CcSEcCtD
Bortezomib—Rash—Methylprednisolone—ulcerative colitis	2.51e-05	0.000154	CcSEcCtD
Bortezomib—Dermatitis—Methylprednisolone—ulcerative colitis	2.51e-05	0.000153	CcSEcCtD
Bortezomib—Urticaria—Prednisone—ulcerative colitis	2.51e-05	0.000153	CcSEcCtD
Bortezomib—Headache—Triamcinolone—ulcerative colitis	2.5e-05	0.000153	CcSEcCtD
Bortezomib—Headache—Methylprednisolone—ulcerative colitis	2.5e-05	0.000153	CcSEcCtD
Bortezomib—Body temperature increased—Prednisone—ulcerative colitis	2.5e-05	0.000153	CcSEcCtD
Bortezomib—Abdominal pain—Prednisone—ulcerative colitis	2.5e-05	0.000153	CcSEcCtD
Bortezomib—Diarrhoea—Dexamethasone—ulcerative colitis	2.48e-05	0.000152	CcSEcCtD
Bortezomib—Diarrhoea—Betamethasone—ulcerative colitis	2.48e-05	0.000152	CcSEcCtD
Bortezomib—Dizziness—Betamethasone—ulcerative colitis	2.4e-05	0.000147	CcSEcCtD
Bortezomib—Dizziness—Dexamethasone—ulcerative colitis	2.4e-05	0.000147	CcSEcCtD
Bortezomib—Nausea—Triamcinolone—ulcerative colitis	2.37e-05	0.000145	CcSEcCtD
Bortezomib—Nausea—Methylprednisolone—ulcerative colitis	2.37e-05	0.000145	CcSEcCtD
Bortezomib—Hypersensitivity—Prednisone—ulcerative colitis	2.33e-05	0.000142	CcSEcCtD
Bortezomib—Vomiting—Betamethasone—ulcerative colitis	2.31e-05	0.000141	CcSEcCtD
Bortezomib—Vomiting—Dexamethasone—ulcerative colitis	2.31e-05	0.000141	CcSEcCtD
Bortezomib—Rash—Betamethasone—ulcerative colitis	2.29e-05	0.00014	CcSEcCtD
Bortezomib—Rash—Dexamethasone—ulcerative colitis	2.29e-05	0.00014	CcSEcCtD
Bortezomib—Dermatitis—Dexamethasone—ulcerative colitis	2.28e-05	0.00014	CcSEcCtD
Bortezomib—Dermatitis—Betamethasone—ulcerative colitis	2.28e-05	0.00014	CcSEcCtD
Bortezomib—Headache—Dexamethasone—ulcerative colitis	2.27e-05	0.000139	CcSEcCtD
Bortezomib—Headache—Betamethasone—ulcerative colitis	2.27e-05	0.000139	CcSEcCtD
Bortezomib—Asthenia—Prednisone—ulcerative colitis	2.27e-05	0.000138	CcSEcCtD
Bortezomib—Pruritus—Prednisone—ulcerative colitis	2.23e-05	0.000137	CcSEcCtD
Bortezomib—Diarrhoea—Prednisone—ulcerative colitis	2.16e-05	0.000132	CcSEcCtD
Bortezomib—Nausea—Betamethasone—ulcerative colitis	2.15e-05	0.000132	CcSEcCtD
Bortezomib—Nausea—Dexamethasone—ulcerative colitis	2.15e-05	0.000132	CcSEcCtD
Bortezomib—Dizziness—Prednisone—ulcerative colitis	2.09e-05	0.000128	CcSEcCtD
Bortezomib—Vomiting—Prednisone—ulcerative colitis	2.01e-05	0.000123	CcSEcCtD
Bortezomib—Rash—Prednisone—ulcerative colitis	1.99e-05	0.000122	CcSEcCtD
Bortezomib—Dermatitis—Prednisone—ulcerative colitis	1.99e-05	0.000122	CcSEcCtD
Bortezomib—Headache—Prednisone—ulcerative colitis	1.98e-05	0.000121	CcSEcCtD
Bortezomib—Nausea—Prednisone—ulcerative colitis	1.88e-05	0.000115	CcSEcCtD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.24e-05	0.000135	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—DLD—ulcerative colitis	1.24e-05	0.000135	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—NFKB1—ulcerative colitis	1.24e-05	0.000134	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—NFKB1—ulcerative colitis	1.23e-05	0.000134	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.23e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—NFKB1—ulcerative colitis	1.22e-05	0.000133	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—ADCY5—ulcerative colitis	1.19e-05	0.000129	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—ADCY5—ulcerative colitis	1.19e-05	0.000129	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—ADCY5—ulcerative colitis	1.19e-05	0.000129	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—ADCY5—ulcerative colitis	1.17e-05	0.000128	CbGpPWpGaD
Bortezomib—PSMB1—Cell Cycle—TP53—ulcerative colitis	1.16e-05	0.000126	CbGpPWpGaD
Bortezomib—PSMB5—Cell Cycle—TP53—ulcerative colitis	1.16e-05	0.000126	CbGpPWpGaD
Bortezomib—PSMB2—Cell Cycle—TP53—ulcerative colitis	1.16e-05	0.000126	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.15e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—JAK2—ulcerative colitis	1.15e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—JAK2—ulcerative colitis	1.15e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—JAK2—ulcerative colitis	1.15e-05	0.000125	CbGpPWpGaD
Bortezomib—PSMB8—Cell Cycle—TP53—ulcerative colitis	1.14e-05	0.000124	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—JAK2—ulcerative colitis	1.13e-05	0.000123	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IFNG—ulcerative colitis	1.13e-05	0.000122	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IFNG—ulcerative colitis	1.13e-05	0.000122	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IFNG—ulcerative colitis	1.13e-05	0.000122	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.12e-05	0.000122	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—RELA—ulcerative colitis	1.11e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—STAT3—ulcerative colitis	1.11e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—RELA—ulcerative colitis	1.11e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—RELA—ulcerative colitis	1.11e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IFNG—ulcerative colitis	1.11e-05	0.000121	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—STAT3—ulcerative colitis	1.1e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—PTGS2—ulcerative colitis	1.1e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—STAT3—ulcerative colitis	1.1e-05	0.00012	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—PTGS2—ulcerative colitis	1.1e-05	0.000119	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—RELA—ulcerative colitis	1.09e-05	0.000119	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—PTGS2—ulcerative colitis	1.09e-05	0.000119	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD4—ulcerative colitis	1.09e-05	0.000118	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD4—ulcerative colitis	1.09e-05	0.000118	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD4—ulcerative colitis	1.09e-05	0.000118	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD4—ulcerative colitis	1.07e-05	0.000117	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PPARG—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PPARG—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PPARG—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—PSMB2—Disease—JAK2—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—PSMB1—Disease—JAK2—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—PSMB5—Disease—JAK2—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—DLD—ulcerative colitis	1.06e-05	0.000115	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PPARG—ulcerative colitis	1.05e-05	0.000114	CbGpPWpGaD
Bortezomib—PSMB8—Disease—JAK2—ulcerative colitis	1.04e-05	0.000114	CbGpPWpGaD
Bortezomib—PSMA1—Disease—STAT3—ulcerative colitis	1.03e-05	0.000112	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CALM3—ulcerative colitis	1.02e-05	0.000111	CbGpPWpGaD
Bortezomib—PSMD1—Disease—STAT3—ulcerative colitis	1.02e-05	0.000111	CbGpPWpGaD
Bortezomib—PSMD2—Disease—STAT3—ulcerative colitis	1.02e-05	0.00011	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL1B—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL1B—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL1B—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CD4—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CD4—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CD4—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL2—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL2—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL2—ulcerative colitis	1e-05	0.000109	CbGpPWpGaD
Bortezomib—PSMB1—Disease—PTGS2—ulcerative colitis	9.96e-06	0.000108	CbGpPWpGaD
Bortezomib—PSMB2—Disease—PTGS2—ulcerative colitis	9.96e-06	0.000108	CbGpPWpGaD
Bortezomib—PSMB5—Disease—PTGS2—ulcerative colitis	9.96e-06	0.000108	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL1B—ulcerative colitis	9.9e-06	0.000108	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CD4—ulcerative colitis	9.89e-06	0.000108	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL2—ulcerative colitis	9.86e-06	0.000107	CbGpPWpGaD
Bortezomib—PSMB8—Disease—PTGS2—ulcerative colitis	9.82e-06	0.000107	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	9.79e-06	0.000107	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—JAK2—ulcerative colitis	9.78e-06	0.000106	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—JAK2—ulcerative colitis	9.73e-06	0.000106	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—JAK2—ulcerative colitis	9.69e-06	0.000105	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—ALB—ulcerative colitis	9.53e-06	0.000104	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—ALB—ulcerative colitis	9.53e-06	0.000104	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—ALB—ulcerative colitis	9.53e-06	0.000104	CbGpPWpGaD
Bortezomib—PSMA1—Disease—TGFB1—ulcerative colitis	9.5e-06	0.000103	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—RELA—ulcerative colitis	9.47e-06	0.000103	CbGpPWpGaD
Bortezomib—PSMD1—Disease—TGFB1—ulcerative colitis	9.46e-06	0.000103	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CHP1—ulcerative colitis	9.45e-06	0.000103	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—RELA—ulcerative colitis	9.43e-06	0.000103	CbGpPWpGaD
Bortezomib—PSMD2—Disease—TGFB1—ulcerative colitis	9.41e-06	0.000102	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—ALB—ulcerative colitis	9.4e-06	0.000102	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—RELA—ulcerative colitis	9.38e-06	0.000102	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—NFKB1—ulcerative colitis	9.36e-06	0.000102	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—NFKB1—ulcerative colitis	9.36e-06	0.000102	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—NFKB1—ulcerative colitis	9.36e-06	0.000102	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—NFKB1—ulcerative colitis	9.23e-06	0.0001	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CXCL8—ulcerative colitis	8.93e-06	9.71e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CXCL8—ulcerative colitis	8.88e-06	9.67e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CXCL8—ulcerative colitis	8.84e-06	9.62e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.77e-06	9.54e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL2—ulcerative colitis	8.53e-06	9.28e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL2—ulcerative colitis	8.49e-06	9.24e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL2—ulcerative colitis	8.45e-06	9.19e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—STAT3—ulcerative colitis	8.41e-06	9.16e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—STAT3—ulcerative colitis	8.41e-06	9.16e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—STAT3—ulcerative colitis	8.41e-06	9.16e-05	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—PTGS2—ulcerative colitis	8.34e-06	9.08e-05	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—PTGS2—ulcerative colitis	8.34e-06	9.08e-05	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—PTGS2—ulcerative colitis	8.34e-06	9.08e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—STAT3—ulcerative colitis	8.3e-06	9.03e-05	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—PTGS2—ulcerative colitis	8.22e-06	8.95e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—DLD—ulcerative colitis	8.16e-06	8.88e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—MMP9—ulcerative colitis	8.07e-06	8.79e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	8.04e-06	8.75e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—MMP9—ulcerative colitis	8.03e-06	8.74e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS1—ulcerative colitis	8.02e-06	8.73e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—MMP9—ulcerative colitis	8e-06	8.7e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NFKB1—ulcerative colitis	7.99e-06	8.69e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ABCB1—ulcerative colitis	7.97e-06	8.67e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NFKB1—ulcerative colitis	7.95e-06	8.65e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NFKB1—ulcerative colitis	7.91e-06	8.61e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.89e-06	8.58e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—STAT3—ulcerative colitis	7.77e-06	8.45e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—STAT3—ulcerative colitis	7.77e-06	8.45e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—STAT3—ulcerative colitis	7.77e-06	8.45e-05	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—IL6—ulcerative colitis	7.76e-06	8.44e-05	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—IL6—ulcerative colitis	7.72e-06	8.4e-05	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—IL6—ulcerative colitis	7.68e-06	8.36e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—STAT3—ulcerative colitis	7.66e-06	8.33e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ADCY5—ulcerative colitis	7.43e-06	8.09e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—JAK2—ulcerative colitis	7.41e-06	8.07e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—JAK2—ulcerative colitis	7.41e-06	8.07e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—JAK2—ulcerative colitis	7.41e-06	8.07e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	7.35e-06	8e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—JAK2—ulcerative colitis	7.31e-06	7.95e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.23e-06	7.87e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CALM3—ulcerative colitis	7.22e-06	7.86e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TGFB1—ulcerative colitis	7.2e-06	7.84e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TGFB1—ulcerative colitis	7.2e-06	7.84e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TGFB1—ulcerative colitis	7.2e-06	7.84e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—STAT3—ulcerative colitis	7.18e-06	7.81e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RELA—ulcerative colitis	7.18e-06	7.81e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RELA—ulcerative colitis	7.18e-06	7.81e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RELA—ulcerative colitis	7.18e-06	7.81e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.18e-06	7.81e-05	CbGpPWpGaD
Bortezomib—PSMA1—Disease—IL6—ulcerative colitis	7.16e-06	7.79e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—STAT3—ulcerative colitis	7.14e-06	7.77e-05	CbGpPWpGaD
Bortezomib—PSMD1—Disease—IL6—ulcerative colitis	7.13e-06	7.75e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—STAT3—ulcerative colitis	7.11e-06	7.74e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TGFB1—ulcerative colitis	7.1e-06	7.73e-05	CbGpPWpGaD
Bortezomib—PSMD2—Disease—IL6—ulcerative colitis	7.09e-06	7.72e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RELA—ulcerative colitis	7.08e-06	7.7e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.9e-06	7.51e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CXCL8—ulcerative colitis	6.76e-06	7.36e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CXCL8—ulcerative colitis	6.76e-06	7.36e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CXCL8—ulcerative colitis	6.76e-06	7.36e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CXCL8—ulcerative colitis	6.67e-06	7.26e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TGFB1—ulcerative colitis	6.65e-06	7.24e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TGFB1—ulcerative colitis	6.62e-06	7.21e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CALM3—ulcerative colitis	6.62e-06	7.2e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TGFB1—ulcerative colitis	6.59e-06	7.17e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	6.56e-06	7.14e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	6.54e-06	7.12e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL2—ulcerative colitis	6.46e-06	7.04e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL2—ulcerative colitis	6.46e-06	7.04e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL2—ulcerative colitis	6.46e-06	7.04e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	6.45e-06	7.02e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL2—ulcerative colitis	6.37e-06	6.94e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.33e-06	6.88e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—MMP9—ulcerative colitis	6.12e-06	6.66e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—MMP9—ulcerative colitis	6.12e-06	6.66e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—MMP9—ulcerative colitis	6.12e-06	6.66e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NFKB1—ulcerative colitis	6.05e-06	6.59e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NFKB1—ulcerative colitis	6.05e-06	6.59e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NFKB1—ulcerative colitis	6.05e-06	6.59e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS1—ulcerative colitis	6.03e-06	6.57e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—MMP9—ulcerative colitis	6.03e-06	6.56e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS1—ulcerative colitis	5.98e-06	6.51e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NFKB1—ulcerative colitis	5.97e-06	6.49e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CALM3—ulcerative colitis	5.91e-06	6.43e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.88e-06	6.4e-05	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—IL6—ulcerative colitis	5.88e-06	6.4e-05	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—IL6—ulcerative colitis	5.88e-06	6.4e-05	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—IL6—ulcerative colitis	5.88e-06	6.4e-05	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—IL6—ulcerative colitis	5.79e-06	6.31e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.65e-06	6.14e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ABCB1—ulcerative colitis	5.61e-06	6.11e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	5.59e-06	6.09e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PPARG—ulcerative colitis	5.54e-06	6.03e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TP53—ulcerative colitis	5.48e-06	5.96e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TP53—ulcerative colitis	5.45e-06	5.93e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—STAT3—ulcerative colitis	5.44e-06	5.92e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—STAT3—ulcerative colitis	5.44e-06	5.92e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—STAT3—ulcerative colitis	5.44e-06	5.92e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CALM3—ulcerative colitis	5.43e-06	5.91e-05	CbGpPWpGaD
Bortezomib—PSMB5—Disease—IL6—ulcerative colitis	5.43e-06	5.91e-05	CbGpPWpGaD
Bortezomib—PSMB2—Disease—IL6—ulcerative colitis	5.43e-06	5.91e-05	CbGpPWpGaD
Bortezomib—PSMB1—Disease—IL6—ulcerative colitis	5.43e-06	5.91e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TP53—ulcerative colitis	5.43e-06	5.9e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CALM3—ulcerative colitis	5.39e-06	5.86e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—STAT3—ulcerative colitis	5.36e-06	5.84e-05	CbGpPWpGaD
Bortezomib—PSMB8—Disease—IL6—ulcerative colitis	5.35e-06	5.82e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ADCY5—ulcerative colitis	5.24e-06	5.7e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	5.15e-06	5.6e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	5.15e-06	5.6e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS1—ulcerative colitis	5.11e-06	5.56e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TGFB1—ulcerative colitis	5.04e-06	5.49e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TGFB1—ulcerative colitis	5.04e-06	5.49e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TGFB1—ulcerative colitis	5.04e-06	5.49e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	5.03e-06	5.47e-05	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—IL6—ulcerative colitis	5.01e-06	5.46e-05	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—IL6—ulcerative colitis	4.99e-06	5.43e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ALB—ulcerative colitis	4.98e-06	5.42e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TGFB1—ulcerative colitis	4.97e-06	5.41e-05	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—IL6—ulcerative colitis	4.97e-06	5.4e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	4.8e-06	5.22e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CALM3—ulcerative colitis	4.6e-06	5.01e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	4.59e-06	5e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	4.4e-06	4.79e-05	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—PTGS2—ulcerative colitis	4.36e-06	4.75e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	4.29e-06	4.66e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ABCB1—ulcerative colitis	4.23e-06	4.6e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ABCB1—ulcerative colitis	4.19e-06	4.56e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TP53—ulcerative colitis	4.15e-06	4.52e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TP53—ulcerative colitis	4.15e-06	4.52e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TP53—ulcerative colitis	4.15e-06	4.52e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TP53—ulcerative colitis	4.09e-06	4.45e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	3.95e-06	4.29e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ADCY5—ulcerative colitis	3.94e-06	4.29e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ADCY5—ulcerative colitis	3.91e-06	4.25e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PPARG—ulcerative colitis	3.91e-06	4.25e-05	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—IL6—ulcerative colitis	3.8e-06	4.14e-05	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—IL6—ulcerative colitis	3.8e-06	4.14e-05	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—IL6—ulcerative colitis	3.8e-06	4.14e-05	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—IL6—ulcerative colitis	3.75e-06	4.08e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PPARG—ulcerative colitis	3.58e-06	3.9e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ABCB1—ulcerative colitis	3.58e-06	3.9e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CALM3—ulcerative colitis	3.55e-06	3.87e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ALB—ulcerative colitis	3.51e-06	3.82e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ADCY5—ulcerative colitis	3.34e-06	3.63e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ALB—ulcerative colitis	3.22e-06	3.5e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PPARG—ulcerative colitis	3.2e-06	3.48e-05	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—PTGS2—ulcerative colitis	3.07e-06	3.34e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.94e-06	3.2e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PPARG—ulcerative colitis	2.91e-06	3.17e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ALB—ulcerative colitis	2.87e-06	3.13e-05	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	2.82e-06	3.07e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	2.76e-06	3.01e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ALB—ulcerative colitis	2.64e-06	2.88e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ALB—ulcerative colitis	2.62e-06	2.85e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	2.58e-06	2.8e-05	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	2.51e-06	2.74e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PPARG—ulcerative colitis	2.49e-06	2.71e-05	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—PTGS2—ulcerative colitis	2.31e-06	2.52e-05	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—PTGS2—ulcerative colitis	2.29e-06	2.49e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ALB—ulcerative colitis	2.24e-06	2.44e-05	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—PTGS2—ulcerative colitis	1.96e-06	2.13e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PPARG—ulcerative colitis	1.92e-06	2.09e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ALB—ulcerative colitis	1.73e-06	1.88e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	1.51e-06	1.65e-05	CbGpPWpGaD
